Histone H4 deacetylation plays a critical role in early gene silencing during neuronal apoptosis by Pelzel, Heather R et al.
Pelzel et al. BMC Neuroscience 2010, 11:62
http://www.biomedcentral.com/1471-2202/11/62
Open Access RESEARCH ARTICLE
BioMed  Central
© 2010 Pelzel et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
Research article Histone H4 deacetylation plays a critical role in 
early gene silencing during neuronal apoptosis
Heather R Pelzel1,2, Cassandra L Schlamp2 and Robert W Nickells*2,3
Abstract
Background: Silencing of normal gene expression occurs early in the apoptosis of neurons, well before the cell is 
committed to the death pathway, and has been extensively characterized in injured retinal ganglion cells. The 
causative mechanism of this widespread change in gene expression is unknown. We investigated whether an 
epigenetic change in active chromatin, specifically histone H4 deacetylation, was an underlying mechanism of gene 
silencing in apoptotic retinal ganglion cells (RGCs) following an acute injury to the optic nerve.
Results: Histone deacetylase 3 (HDAC3) translocates to the nuclei of dying cells shortly after lesion of the optic nerve 
and is associated with an increase in nuclear HDAC activity and widespread histone deacetylation. H4 in promoters of 
representative genes was rapidly and indiscriminately deacetylated, regardless of the gene examined. As apoptosis 
progressed, H4 of silenced genes remained deacetylated, while H4 of newly activated genes regained, or even 
increased, its acetylated state. Inhibition of retinal HDAC activity with trichostatin A (TSA) was able to both preserve the 
expression of a representative RGC-specific gene and attenuate cell loss in response to optic nerve damage.
Conclusions: These data indicate that histone deacetylation plays a central role in transcriptional dysregulation in 
dying RGCs. The data also suggests that HDAC3, in particular, may feature heavily in apoptotic gene silencing.
Background
Intrinsic apoptosis in neurons culminates in BAX activa-
tion and translocation to the mitochondria, the release of
cytochrome c, and the activation of the caspase cascade.
BAX translocation marks the committed step of the cell
death process [1]. Therefore, investigation of the apop-
totic pathway prior to BAX involvement is an important
element of developing strategies to intervene in neuronal
cell death.
An early event in apoptosis is silencing of normal gene
expression. In addition to this, new transcription,
required for apoptosis, is activated. This change in tran-
scriptional profile occurs in several models of neurode-
generation, including Huntington's Disease, Alzheimer's
Disease, Parkinson's Disease, amyotrophic lateral sclero-
sis, spinocerebellar ataxia type 3, and the optic neuropa-
thy glaucoma [2-10]. In glaucoma, retinal ganglion cells
(RGCs) execute a typical intrinsic apoptotic program.
Changes in transcription of several genes in injured
RGCs have been shown in experimental glaucoma and
after acute injury to the optic nerve. Genes that decrease
in expression in RGCs include several that are specifically
expressed in these cells, such as Thy1,  Brn3b,  Nrn1,
Fem1c, and Sncg, [3-5,11-16], as well as several non-cell
type specific genes, including BclXl, TrkB, and members
of the neurofilament gene family [3,13,14,17]. Of the
genes with increased expression, the majority are
proapoptotic or stress response genes, such as Bim, cJun,
and several Hsps and caspases [4,5,18-20]. This change in
the pattern of gene expression in RGCs occurs before
detectable cell loss [4,11,21] and can also be induced by
optic nerve crush (ONC) of Bax knock-out RGCs, indi-
cating that this event occurs early in the apoptotic path-
way. Little investigation has been conducted to
understand the mechanism underlying the down-regula-
tion of normal gene expression. The global nature of gene
silencing in RGCs, however, suggests that epigenetic
changes of the chromatin of actively transcribed genes
may be an early step in apoptosis.
Post-translational modifications of histones are well
known epigenetic changes that regulate chromatin fold-
ing, organization, and gene activity [22]. Histone modifi-
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cations include phosphorylation, methylation,
ubiquitination, and/or acetylation of lysine residues prin-
cipally in the N-terminal tails [23]. While all of these
modifications have an effect on the transcriptional activ-
ity, acetylation has the most direct effect [24]. Acetylated
histones are typically found in transcriptionally active
euchromatic chromatin, whereas transcriptionally inac-
tive heterochromatic chromatin is rich in deacetylated
histones. Theoretically, deacetylation is thought to lead to
a more compact chromatin structure, which limits access
of transcription factors [24]. Alternatively, acetyl groups
may facilitate the interactions of chromatin with specific
transcription factors containing bromodomains, which
recognize and bind acetylated amino acids of other pro-
teins, including histone tails [25]. The acetylation and
deacetylation of histones is controlled by opposing pro-
tein families called histone acetyltransferases (HATs) and
histone deacetylases (HDACs).
Here we show that several RGC specific genes, which
decrease in expression after ONC, exhibit a decrease in
promoter histone acetylation. This deacetylation is
accompanied by an increase in both HDAC2 and HDAC3
expression and the translocation of HDAC3 to the nuclei
of dying RGCs. Additionally, inhibition of HDAC activity
is able to prevent the ONC-mediated silencing of at least
one RGC-specific gene and attenuate the level of RGC
death. These results represent one of the first documen-
tations of epigenetic changes associated with neuronal
cell death and may provide insight into some of the earli-
est changes occurring in dying RGCs.
Results
Nuclear HDAC activity is increased after ONC
Nuclear HDAC activity was measured in retinal nuclear
protein extracts isolated at 1, 3, 5, and 7 days following
ONC (Figure 1A). No significant change was detected in
fellow control eyes (OD). Experimental eyes (OS) exhib-
ited an ~50% increase in activity at day 5 post ONC (P =
0.0014). Activity was also significantly higher than con-
trol eyes at 7 days post ONC (P = 0.0006), although lower
than day 5 experimental eyes. Nuclear HDAC activity in
experimental and control eyes was completely inhibited
by trichostatin A (TSA), indicating the presence of pre-
dominantly class I and II HDACs in this fraction (Figure
1A).
Dose-dependent inhibition of nuclear HDAC activity
was also performed with different inhibitors to help eval-
uate which HDACs were active both before and after
O N C .  T S A - m e d i a t e d  i n h i b i t i o n  o f  c o n t r o l  a n d  c r u s h
nuclear extracts from day 5 retinas showed a dose-depen-
dent decrease in HDAC activity with an IC50 ranging
from 15 to 22 nM (Figure 1B). A similar loss of activity
was observed in extracts treated with the selective class I
inhibitor, valproic acid (data not shown). To further refine
Figure 1 Nuclear histone deacetylase (HDAC) activity in the reti-
na is increased following optic nerve crush (ONC). The data shown 
was adjusted for protein input and normalized to day 0 control sam-
ples. The mean (± SE) HDAC activity is shown (n = 3-5 retinas per data 
point). (A) No increase in HDAC activity was observed in control eyes 
(OD) post ONC. There was a significant increase in nuclear HDAC activ-
ity in the crush samples (OS) at both 5 and 7 days post ONC (*P = 
0.0014 for day 5 vs. day 0 and **P = 0.0006 for day 7 vs. day 0). HDAC 
activity in this assay was completely inhibited by 500 nM of trichostatin 
A (TSA). (B) HDAC activity in nuclear extracts from retinas of mice 5 days 
post ONC was titrated with TSA (n = 3 samples at each concentration). 
Both control and experimental samples displayed similar inhibition ki-
netics with an IC50 value ranging from 15 -- 22 nM TSA, comparable to 
the reported IC50 values of 1 -- 10 nM for class I HDACs [61]. (C) HDAC 
activity in the same samples as (B) was titrated with the HDAC2 and 
HDAC3 selective inhibitor apicidin [62]. Apicidin results in an 80% re-
duction in nuclear HDAC activity, yielding an IC50 ranging from 1.88 to 
2.55 nM, consistent with the reported HDAC3 IC50 for apicidin [26]. 
These data suggest that the majority of nuclear HDAC activity in the 
retina is provided by class I HDACs, principally HDAC2 and HDAC3. 
AFU, arbitrary fluorescence units.Pelzel et al. BMC Neuroscience 2010, 11:62
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which class I HDACs may be contributing to the retinal
nuclear activity, we repeated this experiment using apici-
din, which is selective for HDACs 2 and 3. HDAC activity
was also nearly completely inhibited with apicidin, yield-
ing an IC50 ranging from 1.88 to 2.55 nM (Figure 1C).
These values agreed with the reported IC50  value for
HDAC3 (2.5 nM) using this inhibitor [26] and suggest
that HDACs 2 and 3 contribute the majority of nuclear
HDAC activity in the retina.
In addition to measuring nuclear HDAC activity, we
also characterized which HDACs were expressed in the
mouse retina by both mRNA and protein analysis.
HDACs 1-5 were selectively examined because they have
all been reported to be active in nuclei and are known to
affect histone acetylation levels [27]. By RT-PCR and
western blot analysis, HDACs 1, 2, 3, and 5, but not
HDAC4 were detected in normal retinas (Figure 2A). At
the protein level, bands of 59 kD and 49 kD, correspond-
ing to HDACs 2 and 3, respectively, appeared to be most
abundant. This is similar to a previous report of the pat-
tern of HDACs expressed in normal brain tissue [27]. To
examine the change in HDAC expression in response to
ONC, quantitative RT-PCR (qPCR) analysis was con-
ducted on samples isolated from several time points fol-
lowing surgery (Figure 2B). By 1 day post ONC, the
mRNAs for Hdacs 2 and 3 doubled (P = 0.0098 and P =
0.0089, respectively), while transcripts for Hdacs 1 and 5
showed modest, but not significant increases. At 3 days
post ONC, only Hdac3 transcripts remained significantly
elevated (P = 0.0024). By 7 days post ONC, no significant
elevation of any of the examined Hdacs was detected.
HDACs 2 and 3 in injured retinas
Since both Hdac 2 and 3 transcripts showed a significant
increase following ONC and the majority of HDAC activ-
ity was sensitive to apicidin, we characterized these
HDACs in the retina before and after ONC. To determine
the localization of these isoforms, immunofluorescence
was performed on retinal cryosections from control and
crush eyes. Both HDAC2 and HDAC3 were present in
cells of the ganglion cell layer (GCL) and inner nuclear
layer (INL) of control eyes (Figure 3A). At higher magnifi-
cation of the GCL of control retinas (Figure 3B, top pan-
els), HDAC2 colocalized with 4,6-diamindino-2-
phenylindole (DAPI), indicating that it was nuclear, con-
sistent with reports that this is an exclusively nuclear pro-
tein [27]. In contrast, HDAC3 labeling was diffuse and
appeared to be predominantly cytoplasmic with minimal
overlap with DAPI labeling. This was also in agreement
with previous reports that HDAC3 contains both a
nuclear localization signal and a nuclear export signal
[27], and can exist in both the cytoplasm and nuclei of
cells [28].
Because subcellular localization of HDACs is a com-
mon mechanism of controlling HDAC activity [29], we
also examined the distribution of HDAC2 and HDAC3
after ONC. In sections from retinas 3 days post ONC
(Figure 3B, lower panels), HDAC2 remained localized to
nuclei of the GCL. HDAC3 localization in the GCL, how-
ever, appeared to change after ONC, with cells showing
both cytoplasmic and nuclear localization, as determined
by colabeling with DAPI staining (Figure 3B and addi-
tional file 1: Localization of HDACs 2 and 3 before and
after optic nerve crush). To confirm these findings, west-
ern blot analysis was conducted on nuclear and cytoplas-
mic fractions isolated from control and crush retinas. As
shown in Figure 3C, a band at 59 kD, corresponding to
HDAC2, was present in the nuclear fractions of both con-
trol and ONC retinas. A 49 kD band, corresponding to
HDAC3, was present in the cytoplasmic fraction from
control retinas, but was both cytoplasmic and nuclear in
the experimental crush retinas consistent with the
Figure 2 HDACs 2 and 3 are prominently expressed in the mouse 
retina and increase in expression following optic nerve injury. (A) 
The presence of transcript and protein of several HDAC isoforms was 
characterized for the murine retina. HDACs 1-5 were examined as they 
have all been shown to deacetylate nuclear histones. Left panel, non-
quantitative RT-PCR of control retina cDNA generated cDNA amplim-
ers corresponding to Hdacs 1-3 and 5, but not Hdac4. The identity of 
each amplimer was verified by sequencing. Right panel, HDAC proteins 
were identified in control retina lysates by western blot analysis using 
antibodies against the indicated HDAC isoforms. Bands of the reported 
nuclear weights corresponding to HDACs 1-3 and 5 were detected. 
Consistent with the RT-PCR experiments, no band was detected for 
HDAC4. (B) Changes in HDAC transcript abundance after ONC were an-
alyzed by qPCR (n = 8-10 retinas per time point). Transcript levels were 
expressed as the ratio of crush (OS): control (OD) retinas, and this ratio 
was normalized to day 0 samples. There were modest, but significant 
increases in Hdacs 2 and 3 at 1day post crush (*P = 0.0098 and P = 
0.0089, respectively) and this increase persisted to 3 days post crush for 
Hdac3 (*P = 0.0024).Pelzel et al. BMC Neuroscience 2010, 11:62
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Figure 3 HDAC2 and HDAC3 are expressed by cells in the ganglion cell layer (GCL). (A) Nuclei in the GCL and inner nuclear layer (INL) were 
strongly labeled for HDAC2. HDAC3 labeling was more diffuse, but also labeled cells in the GCL and INL. Scale bar = 25 μm. (B) Sections from control 
retinas and retinas 3 days after optic nerve crush. High-magnification images of the GCL are shown. Sections were counter-stained with DAPI to high-
light nuclei. In control retinas, HDAC2 was localized to nuclei of GCL cells. HDAC3 labeling was principally in the cytoplasm of GCL cells, although some 
label appeared to be distributed in or around cellular nuclei. In the GCL of crush retinas, HDAC2 remained nuclear (lower left), while HDAC3 labeling 
was clearly detected in the nuclei of some cells. Scale bar = 5 μm. Photomicrographs of the individual channels of these merged images are shown 
in additional file 1. (C) Western blot analysis of HDACs 2 and 3 in cytoplasmic (C) and nuclear (N) fractions of control and experimental retinas 3 days 
after optic nerve crush. A 59 kD band corresponding to HDAC2 was exclusive to the nuclear fractions in both control and crush retinas. The 49 kD 
band of HDAC3 was present only in the cytoplasmic fraction in the control eyes, but was distributed between both nuclear and cytoplasmic fractions 
in the crush samples suggesting nuclear translocation of HDAC3 after ONC. Control antibodies for AcH4 (nuclear) and GAPDH (cytoplasmic) are shown 
to monitor the relative purity of each fraction.Pelzel et al. BMC Neuroscience 2010, 11:62
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nuclear translocation of this protein after ONC. As a con-
trol for the fractionation, the blots were also probed for
acetylated histone H4 and GAPDH as nuclear and cyto-
plasmic controls, respectively.
Histone H4 acetylation in the GCL decreases following ONC
Histones H3 and H4 are substrates of HDACs 2 and 3. In
particular, deacetylation of at least 5 different lysine resi-
dues of H4 have been implicated in transcriptional silenc-
ing [24]. To determine if there was a decrease in
acetylation of histones in injured RGCs, concomitant
with the increase in HDAC activity and increased nuclear
presence, we examined retinal cryosections taken from
control and experimental retinas with a polyclonal anti-
body against pan-acetylated histone H4 (AcH4). Figure
4A shows low magnification images of the INL and GCL
(left panels), and higher magnification images of just the
GCL (right panels). Nuclear labeling was detected in both
the INL and GCL of the control retinas (top panels). After
ONC, the label intensity remained consistent in the INL,
but there was an apparent and progressive decrease in
labeling of the GCL. High magnification images (Figure
4A, right panels) indicated that the decrease in label
intensity was not only due to a loss of cells in this layer,
but also to a decrease in the labeling of individual cells
within this layer. To verify the decrease in label intensity
of individual nuclei in the GCL, fluorescent pixel inten-
sity of cells in this layer were measured and normalized to
pixel intensity of AcH4 labeling in the INL of the same
section. Compared to control eyes, the average AcH4
label intensity of GCL nuclei in experimental retinas pro-
gressively decreased to ~45% by 5 days post ONC (Figure
4B, P < 0.0001 for days 1, 3, and 5 vs. control retinas). By 7
days post ONC, many RGCs are in the later stages of
apoptosis [30]. Consistent with this, we observed an
actual increase in the average AcH4 label intensity of cells
remaining in this layer at 7 days. Although this average
was still significantly below control levels (P = 0.04), it
may reflect that unaffected amacrine cells made up a
larger proportion of nuclei assayed at this time point.
Characterization of HDAC3 translocation and deacetylation 
of histone H4 in dying cells
The increase in nuclear HDAC3 localization and an
apparent decrease in histone H4 acetylation in some cells
of the GCL following ONC is consistent with the concept
of widespread histone deacetylation taking place in dying
RGCs, which are the principal cell type affected by the
crush procedure. Importantly, we wanted to verify that
these changes were characteristic of dying cells. To
address this, we first identified dying cells in retinal cryo-
sections with an antibody against phosphorylated H2AX
(γH2AX). The phosphorylation of the histone H2A vari-
ant, H2AX, is a known marker of apoptosis, and its
Figure 4 Acetylated histone H4 is depleted in the ganglion cell 
layer (GCL) nuclei following optic nerve crush (ONC). (A) Left panels, 
sections from a control retina and retinas after ONC were labeled for 
acetylated histone H4 (AcH4). Nuclei in the outer nuclear layer (not 
shown), inner nuclear layer (INL) and GCL of the retina were labeled. 
AcH4 labeling in the INL remained constant at all time points exam-
ined. Labeling in the GCL progressively decreased after ONC. Scale bar 
= 20 μm. Right panels, Higher magnification of cells of the GCL after 
ONC. All images were taken at a fixed exposure time. At 1 day post 
ONC, AcH4 labeling was slightly decreased. At 3 days post ONC, several 
nuclei showed pronounced loss of label (arrows). At 5 days post ONC, 
only a subset of cells in the GCL remained labeled for AcH4. Scale bar 
= 10 μm. (B) Quantification of AcH4 staining intensity of cells in the 
GCL. Staining intensity was normalized to AcH4 staining in cells of the 
INL for each section examined. Results are shown as the ratio of stain-
ing intensity between experimental (OS) and control (OD) eyes of the 
same animals (n < 99 cells counted per layer). AcH4 immunoreactivity 
significantly decreased during the first 5 days post ONC (*P ≤ 0.0001 OS 
vs. OD). By 7 days post ONC, AcH4 staining appeared to recover, but 
was still significantly lower than control retinas (**P = 0.041 OS vs. OD). 
Staining recovery may reflect an increase in the proportion of unaffect-
ed GCL amacrine cells as ganglion cells die.Pelzel et al. BMC Neuroscience 2010, 11:62
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appearance coincides with early onset DNA damage that
precedes mitochondrial involvement in the cell death
program [31]. In the GCL of injured retinas, γH2AX
underwent a progressive change in localization that
allowed us to group the cells into three stages of γH2AX
labeling (Figure 5A). Stage I labeling was principally
found in control retinas and in some GCL cells in injured
retinas and was characterized by little to no γH2AX label-
ing except for a densely labeled spot associated with the
nucleoli. Stage II was distinguishable by strong perinu-
clear labeling, while stage III had strong nuclear labeling.
Stage II labeled cells began to appear in the injured GCL
as early as 1 day post ONC. Progressively after this, an
increasing proportion of cells exhibited stage III labeling.
By 5-7 days post ONC, 50-60% of the cells in this layer
were either stage II or stage III for γH2AX, consistent
with estimates that RGCs make up 60% of the cells in the
GCL (Figure 5B) [32,33]. To verify labeling in RGCs, we
also retrogradely labeled them with fluorogold prior to
ONC. After crush surgery, an estimated 85% of the fluo-
rogold positive cells exhibited stage II or stage III γH2AX
labeling (Figure 5C).
Figure 6 illustrates the change in HDAC3 and γH2AX
labeling in the retina as RGCs progressed through apop-
tosis. HDAC3 appeared to be cytoplasmic in control cells
(Figure 6A), and shortly after ONC, was found co-local-
ized with stage II γH2AX labeled cells in the cytoplasm
(Figure 6B). In other cells, however, HDAC3 staining was
present in the nuclei, while γH2AX staining was still
localized as a perinuclear ring in the cytoplasm (Figure
6C). In mid-to late stages post ONC, double-labeled cells
in the GCL exhibited stage III γH2AX labeling and
nuclear localization of HDAC3 (Figure 6D-F).
Because of the strictly nuclear presence of AcH4, the
colocalization of AcH4 and γH2AX was much different
than that observed for HDAC3. In control eyes, the nuclei
were strongly labeled for AcH4 and γH2AX was only
present as a spot that was associated with the nucleoli
(Stage I, Figure 7A). Early after ONC, RGCs with stage II
γH2AX localization also presented with strong nuclear
labeling with AcH4 (Figure 7B, C). In stage III labeled
cells, γH2AX and AcH4 colocalization was initially yellow
in merged images, but progressed to orange, then red,
indicative of both an increase in γH2AX intensity and a
decrease in AcH4 labeling (Figure 7D-F). The nuclear
localization of this co-labeling was confirmed with DAPI
staining, which also indicated that cells with nuclear
γH2AX and decreased AcH4 staining exhibited frag-
mented and condensed nuclei typical of apoptotic cells
(See additional file 2: The deacetylation of histone H4
occurs in cells with nuclear γH2AX and DNA fragmenta-
tion).
Promoter deacetylation is associated with a 
downregulation of gene expression in injured RGCs
To correlate the observed decrease in histone H4 acetyla-
tion with gene silencing, we determined if H4 deacetyla-
tion occurred in transcriptionally significant sites, such as
the promoter regions of genes that are downregulated in
RGCs in response to ONC. Following ONC, a number of
genes are known to decrease in expression. A retrospec-
Figure 5 Localization of γH2AX in apoptotic retinal ganglion cells 
(RGCs). Three stages of γH2AX localization in the ganglion cell layer 
(GCL) were apparent. (A) γH2AX labeling in healthy cells (Stage I) was 
detectable as a prominent spot associated with the nucleolus (arrow). 
Stage II labeling was characterized by a cytoplasmic perinuclear ring. 
Strong nuclear labeling (N) was indicative of stage III γH2AX localiza-
tion. Scale bar = 3 μm. (B) Quantification of γH2AX labeling in control 
and crush retinas. In control eyes (day 0), the majority of cells in the GCL 
exhibited stage I labeling with a small number of cells showing stage 
III labeling. As early as 1 day post ONC, stage II labeling was present in 
~40% of cells in the GCL with a small number of stage III labeled cells. 
Stage III labeling increased through days 3, 5, and 7 post ONC. No more 
than 50% of cells in the GCL exhibited stage II or III γH2AX labeling, sug-
gesting that a subset of cells were affected. (C) To verify that the subset 
of γH2AX labeled cells were RGCs, they were prelabeled with Fluoro-
gold (FG) prior to ONC and staining for γH2AX (5 days post ONC). The 
images show 3 FG positive cells in the GCL with stage II γH2AX labeling 
(arrows), while a fourth FG labeled cell (asterisk) shows relatively weak 
γH2AX labeling. In the control eyes, < 15% of FG-positive RGCs exhib-
ited stage II or III γH2AX labeling versus 85% of FG-positive RGCs in ex-
perimental eyes. Scale bar = 10 μm.Pelzel et al. BMC Neuroscience 2010, 11:62
http://www.biomedcentral.com/1471-2202/11/62
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Figure 6 HDAC3 translocates to the nuclei of apoptotic cells. Retinal sections from eyes before optic nerve crush (ONC) and at several points after 
ONC were double labeled with antibodies against HDAC3 (green) and γH2AX (red), to identify apoptotic cells (see Figure 5). (A) Cells in the ganglion 
cell layer prior to ONC exhibited diffuse cytoplasmic HDAC3 labeling and a densely labeled spot of γH2AX (stage I labeling), which associated with the 
nucleoli (arrows). Representative unlabeled nuclei are indicated (N). (B) Following ONC, HDAC3 labeling began to appear in the nuclei (asterisk in 
merged image), while γH2AX labeling was detectable as a cytoplasmic perinuclear ring (stage II labeling, arrowhead). (C) HDAC3 labeling continued 
to increase in the nuclei (asterisks), while the overall intensity of γH2AX labeling increased in both the cytoplasm (arrowhead) and the nuclei, which 
appear yellow in the merged image (asterisks). (D) At later time points post ONC, a greater proportion of cells exhibited nuclear colocalization of 
HDAC3 and γH2AX (stage III labeling, arrowhead). (E, F) HDAC3 and γH2AX labeling continued to colocalize (asterisks), although nuclei of dying cells 
were less well defined. Scale bar = 5 μm.Pelzel et al. BMC Neuroscience 2010, 11:62
http://www.biomedcentral.com/1471-2202/11/62
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Figure 7 Widespread deacetylation of histone H4 occurs in apoptotic cells. Retinal sections from eyes before optic nerve crush (ONC) and at sev-
eral points after ONC were double labeled with antibodies against acetylated histone H4 (AcH4, green) and γH2AX (red), to identify apoptotic cells 
(see Figure 5). (A) Control ganglion cell layer nuclei (N) were strongly labeled for AcH4. Arrows indicate focal γH2AX labeling associated with nucleoli 
(stage I). (B) Shortly after ONC, γH2AX labeling became more apparent as a perinuclear ring, principally localized to the cytoplasm (arrowhead, stage 
II), while nuclei of these cells still exhibited strong labeling for AcH4. (C, D, E) At subsequent time points after ONC, γH2AX labeling in nuclei (N) pro-
gressively increased (stage III), while nuclear AcH4 labeling decreased (asterisk in E). Note a change from green to yellow to red nuclear color in the 
merged panels. (F) By late in the cell death process, nuclei (N) intensely labeled for γH2AX exhibited little to no immunoreactivity to AcH4 (asterisk). 
Scale bar = 5 μm. The decrease in AcH4 labeling, and the presence of γH2AX stage III labeling, also correspond to increased DNA fragmentation as 
assessed by DAPI staining (See additional file 2).Pelzel et al. BMC Neuroscience 2010, 11:62
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tive analysis of the literature indicated that the rapid
decrease in transcript abundance for a majority of genes
roughly follows an exponential decay curve (Figure 8A).
To verify this in a controlled setting, we developed a mini
qPCR array of several mRNAs expressed in RGCs and
used it to monitor the change in transcript abundance in
retinas over the first 7 days post ONC. Similar to the lit-
erature reports, this prospective study also showed the
exponential decay of RGC transcripts (Figure 8B). Two
sets of genes were examined for chromatin immunopre-
cipitation (ChIP) analysis. The first group included Thy1,
Brn3b, Nrn1, and Fem1c, which are expressed predomi-
nately by RGCs in the retina, as well as the anti-apoptotic
gene BclX [3-5,11,14,15]. This group of genes represented
a  s u b s e t  o f  g e n e s  t h a t  e x h i b i t  a  r e p o r t e d  d e c r e a s e  i n
expression after ONC. The second group of genes, Bim
and  cJun, were examined because they undergo an
increase in expression following ONC [5,18]. ChIP assays,
with antibodies against acetylated H4, were performed on
retinas from control and crush eyes followed by qPCR to
quantify the genomic DNA that was collected. The quan-
tification of promoter DNA associated with acetylated
histone H4 is shown in Figure 9 and is expressed as a ratio
of experimental: control retinas. All ratios have been nor-
malized to day 0 controls. Surprisingly, promoter regions
for both down-regulated and up-regulated genes showed
a significant decrease in histone acetylation 1 day post
ONC, with the exception of the promoter for cJun (Figure
9A). Three days post ONC, however, the acetylation pat-
tern of promoter histones was changed and only down-
regulated genes exhibited a decrease in promoter acetyla-
tion (Figure 9B), while promoter H4 acetylation for cJun
had remained at day 0 levels and levels for Bim had signif-
icantly increased ~2-fold. A similar pattern of promoter
acetylation observed 3 days after ONC was also evident
on day 5 post ONC (Figure 9C), except that Bim H4 pro-
moter acetylation had increased further to ~3-fold the
level detected in day 0 retinas.
Inhibition of HDAC activity blocks ONC-induced silencing 
of the Fem1cR3 reporter gene
Although promoter histone deacetylation is associated
with silenced genes in RGCs, these experiments do not
Figure 8 Progressive gene silencing following optic nerve crush (ONC) precedes the loss of retinal ganglion cells (RGCs). Analysis of transcript 
levels of several silenced genes following ONC or optic nerve axotomy. (A) A retrospective analysis of published reports of gene silencing in apoptotic 
RGCs. Each data point represents the mean of values collected by different investigators to simplify the data set shown. One of the earliest demon-
strations of gene silencing in RGCs after optic nerve damage was a quantitative RNase protection assay study for the RGC marker gene Thy1 [11]. These 
data points follow an exponential decay curve described by the equation, y = -18.441 Ln(x) + 55.703. All other data points are shown relative to this 
curve and displayed similar kinetics of silencing. Alternatively, during the first 7 days after ONC less than 1% of the cells had been eliminated (data not 
shown) [11]. Thus, gene silencing precedes cell loss by several days and represents a relatively early event in the apoptotic pathway. (B) Quantitative 
PCR analysis of silenced genes following ONC, graphed over the exponential decay curve of the original Thy1 studies. A similar decline in transcripts 
is evident in a more controlled prospective study. Interestingly, after an initial decline, BclX levels recover, consistent with earlier reports. In addition, 
genes with increases or no change in expression were also examined. Both Gap43 and Bim exhibited increases in transcript level in the experimental 
eye following ONC (145% and 116%, respectively), while S16 remained unchanged (99.8%, data not shown). In independent qPCR experiments, cJun 
transcript levels were also observed to increase modestly, shortly after ONC (112%).
a [11] Transcript abundance quantified by RNase protection assays in mouse ONC.
b [15] Quantified by qPCR in a rat model of axotomy.
c[12] Protein levels quantified by ELISA assays in mouse ONC.
d[14] Transcript abundance quantified by RNase protection assay in rat ONC.
e, f, g[5] Quantified by qPCR following axotomy in rats.
h[17] Transcript abundance measured by quantitative in situ hybridization studies following axotomy in rats.Pelzel et al. BMC Neuroscience 2010, 11:62
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conclusively demonstrate that this epigenetic change is
the controlling mechanism for transcriptional downregu-
lation. To address this, we examined if inhibitors of
HDAC activity could block the ONC-mediated downreg-
ulation of RGC-specific gene expression. For these exper-
iments, we used Fem1cRosa3 (R3) mice, which contain the
βGeo promoter trap reporter in the first intron of the
Fem1c  gene. Previously, we showed that mice express
βGEO in an RGC-specific manner [12]. Additionally, we
have observed a 75% decrease in βGEO total protein and
enzyme activity [12], and a 50% decrease in Fem1c tran-
script levels, by 5 days post ONC (Figure 8A, B). Thus,
the R3 reporter allows for the rapid detection and quanti-
fication of changes in RGC gene expression.
HDAC activity in the retina was inhibited by pretreat-
ment of mice with TSA given as a single intraperitoneal
(i.p.) injection, 24 hours before ONC. Western blot analy-
sis of AcH4 levels in extracts of total retinal protein (Fig-
ure 10A) confirmed inhibition of HDAC activity, which
was exemplified by hyperacetylation of H4. The effects of
TSA were detected as quickly as 2 hours after injection
and persisted as long as 7 days post injection. R3 gene
expression was assessed by βGEO solution assays 5 days
post ONC (Figure 10B). ONC resulted in a 55-75%
decrease in βGEO enzyme activity by 5 days after surgery.
TSA treated mice, however, exhibited significantly more
activity at this time point than mice receiving no injection
or DMSO injections (P = 0.016 and P = 0.003, respec-
tively). In a separate series of experiments, TSA was also
administered as a single intravitreal injection at the time
of ONC surgery. Whole-mounted retinas from these
experiments exhibited βGEO staining in RGCs consistent
with the solution assays (Figure 10C). Taken together,
these data suggested that TSA was able to attenuate the
silencing of the Fem1c gene.
Inhibition of HDAC activity attenuates cell loss following 
ONC
Although histone deacetylation plays a role in modulating
gene silencing during apoptosis, it is unknown if this pro-
cess is a critical stage in the progression of the cell death
program. To address this, we injected mice (i.p.) with the
HDAC inhibitor, TSA, 24 hours prior to ONC. Retinas
were then examined 2 weeks after surgery, which repre-
sents a point when there is normally significant cell loss
[33]. The mice that underwent crush alone, or mice that
received an injection of DMSO prior to ONC, exhibited
comparable losses of 36.4 ± 3.4% and 31.2 ± 2.9% of cells
in the GCL (P = 0.13, Figure 11A). Conversely, mice that
received TSA prior to ONC showed a significant attenua-
tion of cell loss in the GCL (14.4 ± 5.3%) as compared to
both crush alone and crush with DMSO (P = 0.005 and P
= 0.01, respectively). Representative Nissl-stained whole
mounts of retinas from a control eye and each of the
Figure 9 Gene promoter associated histone H4 becomes 
deacetylated following optic nerve crush (ONC). Two gene sets 
were examined by chromatin immunoprecipitation for acetylated H4. 
The first was comprised of genes whose expression had been docu-
mented to decrease during ganglion cell apoptosis (grey bars), includ-
ing Thy1, Brn3b, Fem1c, Nrn1, and BclX (see text). The second set 
consisted of a pair of genes (Bim and cJun) whose expression has been 
documented to increase during apoptosis (black bars). The data is 
shown as a ratio of crush (OS)/control (OD) and has been normalized 
to day 0 levels (dashed line) (n = 6 samples at each time point). (A) At 
1 day post ONC, there was a significant decrease in promoter H4 acety-
lation of most of the genes examined (range of P values was 9.9 × 10-5 
for Thy1 to 0.04 for Bim). Promoter acetylation for cJun was decreased, 
but this was not significant compared to day 0 levels (*P = 0.08). (B) At 
3 days post ONC, the decrease in promoter acetylation persisted for 
down-regulated genes. Conversely, the promoters of genes that are 
typically up-regulated exhibited a detectable increase in H4 acetyla-
tion to normal or above-normal levels. All changes were significantly 
different compared to day 0 levels, with the exceptions of Nrn1 and 
cJun (*P > 0.08). (C) The general pattern of H4 acetylation observed at 
3 days post ONC, remained consistent through 5 days post ONC. Pro-
moters for BclX and cJun exhibited no statistical change from day 0 his-
tone acetylation levels at this stage (*P > 0.1).Pelzel et al. BMC Neuroscience 2010, 11:62
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three treatments are shown in Figure 11B. Although cell
loss was attenuated by treatment with TSA, surviving
cells did exhibit signs of atrophy such as somal shrinkage.
Discussion
Previous studies by our group and others have shown that
silencing of normal gene expression is an early event in
the apoptotic pathway of neurons, including RGCs
[5,11,12,15]. Although microarray studies have carefully
documented early gene expression changes in dying neu-
rons, little attention has been given to understanding the
causative mechanism leading to these widespread
changes. Here we propose that epigenetic changes in
active chromatin, specifically histone deacetylation, are
p a r t  o f  t h e  u n d e r l y i n g  m e c h a n i s m s  o f  a p o p t o t i c  g e n e
silencing.
W e  w e r e  a b l e  t o  d e t ec t  a n  i n c r e a s e  i n  w h o l e  r e t i n a l
nuclear HDAC activity at the earliest time point exam-
ined (1 day post ONC), however, it was not significantly
higher until day 5. This lag in HDAC activity may reflect
that the increase was mainly occurring in the RGCs,
Figure 10 Inhibition of histone deacetylase activity prevents the 
silencing of a reporter gene after optic nerve crush (ONC). (A) 
Western blot analysis of whole retinal acetylated histone H4 (AcH4) fol-
lowing intraperitoneal injection of trichostatin A (TSA) or vehicle con-
trol (DMSO). The times indicated are the time elapsed between 
injection of TSA and collection of the retinas. TSA resulted in hyper-
acetylation of H4 at all time points after treatment. (B) Retinal ganglion 
cell (RGC) specific gene expression was monitored as a function of 
βGalactosidase activity from the βGeo gene trap cassette inserted into 
Fem1c (see Methods). Histograph showing total retinal βGalactosidase 
activity 5 days post ONC. Mean ± SE is shown (n = 8-12 retinas per con-
dition). Retinas with no injection or after DMSO vehicle injection (i.p.) 
exhibited a 50-75% decrease in βGEO activity after ONC. Conversely, 
TSA treated mice exhibited significantly higher βGEO activity following 
ONC than with crush alone or crush with DMSO injection (*P = 0.015 
and P = 0.003, respectively). (C) Retinal wholemounts showing his-
tochemical staining of βGEO enzyme activity, 5 days after ONC. The 
midperipheral region of the superior quadrant of each retina is shown. 
In this experiment, eyes were treated by intravitreal injections of DMSO 
vehicle or TSA at the time of surgery. Control retinas (control) typically 
showed prominent labeling of RGCs. Retinas from eyes that under-
went crush alone (crush) or crush with DMSO treatment (DMSO) both 
showed a marked loss of staining of RGCs. βGEO activity remained ro-
bust in eyes that received TSA injections. Scale bar = 25 μm.
Figure 11 Inhibition of HDAC activity attenuates cell loss follow-
ing optic nerve crush (ONC). Total cell counts in the ganglion cell lay-
er (GCL) were performed to determine the protective effect of HDAC 
inhibition with trichostatin A (TSA) following ONC. (A) Histograph 
showing cell loss in the GCL in crush eyes as a percentage of cells in the 
contralateral control eyes at 2 weeks post ONC. Mean ± SE is shown (n 
= 6-10 retinas per treatment condition). Mice that received no injec-
tion or an injection of DMSO exhibited a 36.4 and 31.2% cell loss, re-
spectively. Mice that were given a TSA injection prior to ONC only 
exhibited a 14.4% cell loss, which was significantly less than that seen 
with no injection or DMSO (*P = 0.005 vs. crush alone, P = 0.01 vs. DM-
SO). (B) Representative Nissl stained whole mounts of the mid-periph-
eral region of mouse retinas 2 weeks after ONC. Retinas after ONC, 
crush alone (crush) or crush with DMSO (DMSO), exhibited a loss of 
cells compared to fellow control eyes (control). TSA treated mice (TSA) 
exhibited less cell loss after ONC, although cells in these retinas ap-
peared smaller due to atrophy associated with optic nerve lesion, as 
described by others [53]. Scale bar = 20 μm.Pelzel et al. BMC Neuroscience 2010, 11:62
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which only comprise 1-2% of the cell population in the
retina. Therefore, day 5 post ONC may represent a point
when a maximum number of RGCs were exhibiting an
increase in HDAC activity. Conversely, because this
experiment was performed on whole retina extracts and
not on RGC-enriched samples, the increase in activity
could possibly be due to changes in other cell types
within the retina. The immunofluorescent studies exam-
ining changes in nuclear histone H4 acetylation, however,
suggest that the changes in HDAC activity are likely lim-
ited to dying cells in the GCL.
Our experiments suggest that HDACs 2 and 3 play a
central role in the process of histone deacetylation during
RGC death. We have focused on HDAC3, principally
because there is a sustained increase in transcripts for
this gene after ONC, and HDAC3 protein translocates to
nuclei of dying cells. It is reasonable to speculate that the
movement of HDAC3 is a principal mechanism that
increases nuclear HDAC activity in RGCs, and that this
leads to the deacetylation of histone H4. We can infer the
sequence of events defining the relationship between
HDAC3 and the deacetylation of H4 by using the expres-
sion and localization of γH2AX to identify the stage of
the apoptotic pathway that any given cell is in (Figure 12
and additional file 3: The change in expression and cellu-
lar distribution of γH2AX provides a temporal indicator
of histone deacetylation in damaged ganglion cells). Early
in dying cells (stage II γH2AX), cytoplasmic HDAC3
appears to translocate to the nucleus in advance of
γH2AX nuclear localization. This is evident by cells,
which exhibit stage II labeling but may be either cytoplas-
mic or nuclear for HDAC3. The majority of these cells are
present by day 1 post ONC, and already show a quantifi-
able decrease in AcH4 (Figure 4). Additionally, qPCR data
show significant increases in Hdac 2 and 3 transcripts by
this day, and ChIP analysis shows significant deacetyla-
tion of target promoters coincident with a dramatic
decrease in transcript abundance from these target genes
(Figures 8 and 9). Thus, by all accounts, a localized
i n c r e a s e  i n  n u c l e a r  H D A C  a c t i v i t y  t h a t  l e a d s  t o  g e n e
silencing by promoter histone deacetylation appears to be
a very early event in the response of the RGC soma after
ONC.
The question that remains, however, is why does there
appear to be a progressive increase in the level of nuclear
HDAC activity and a similar progressive decrease in his-
tone deacetylation after this initial silencing event? Part
of the answer to this may lie in the relative sensitivity of
the different assays used to detect changes in transcript
abundance, promoter acetylation, HDAC activity, and H4
acetylation levels, but more likely the consequences of
deacetylation are two-fold. The early onset of deacetyla-
tion may selectively target actively expressed genes, lead-
ing to gene silencing. Later, progressive and global
deacetylation may be required as the cell continues
through the apoptotic pathway, in order to facilitate the
condensation of the nuclear chromatin into a heterochro-
matic state. Chromatin condensation is one of the mor-
phological hallmarks of apoptosis, and has been clearly
documented in apoptotic RGCs [34,35]. Histone tails in
condensed heterochromatin are generally hypermethy-
lated and hypoacetylated [22]. HDAC3, in particular, may
play a key role in chromatin condensation. Previous stud-
ies have shown that deacetylation of histone H3 by
HDAC3 initiates chromatin condensation during mitosis
by creating a preferred binding site for Aurora B kinase,
which then phosphorylates H3 [36]. This modification of
the histone code is the first of several events that eventu-
ally lead to chromatin condensation.
Although our experiments show that deacetylation of
histones may be a central mechanism of transcriptional
silencing, consistent with other reports [37,38], they do
not exclude involvement of other chromatin modifica-
tions such as the methylation and demethylation of his-
tones. Unlike the association between acetylation status
of histones and transcriptional activity, the role of methy-
lation in regulating transcription is more complicated.
Trimethylation of lysine 4 in histone H3 (H3K4me3), for
example, is associated with transcriptional activity, while
trimethylation of H4K20 is associated with silent chro-
matin [24,39]. Additionally, HDAC activity is often
closely linked to the activity of demethylases, since these
enzymes are part of larger protein complexes. In both
humans and mice, HDAC2 is often part of the REST
complex, which also includes the histone demethylases
RBP2 and AOF2 [40]. Similarly, HDAC3 is a component
of the SMRT/N-CoR complex, which is able to associate
with the histone demethylase JMJD2A [41]. Preliminary
RT-PCR results from our laboratory have shown that
transcripts for both Ncor1  and  Ncor2  (the mouse
homologs to SMRT and N-COR), as well as Rcor2 (COR-
EST) and Aof2, are present in the mouse retina (data not
shown), indicating that the components for active
HDAC3 and HDAC2 complexes are expressed in this tis-
sue.
Modulation of the HAT and HDAC activity balance during 
neurodegeneration
In healthy cells, HAT and HDAC activities are balanced
to regulate transcriptional activity [24]. The disruption of
this balance, as demonstrated through the use of HDAC
inhibitors, can lead to apoptosis principally in rapidly
dividing cells [42,43]. Disruption of the HAT:HDAC bal-
ance also appears to play a role in neurodegenerative dis-
eases, albeit by a mechanism that appears to be different
from the lethal imbalances that cause cancer cell death.
Rather than decreases, relative increases in HDAC activ-
ity contribute to the progression of neuronal apoptosis inPelzel et al. BMC Neuroscience 2010, 11:62
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Figure 12 HDAC3 becomes localized to nuclei prior to the deacetylation of histone H4 in dying cells. Retinal cryosections before and after optic 
nerve crush (ONC) were colabeled with either γH2AX and AcH4 or HDAC3 antibodies. Representative cells from the ganglion cell layer (GCL) are shown 
for four stages of γH2AX localization. (A, B) Control retinas showed nuclear labeling of acetylated H4 (AcH4) and cytoplasmic labeling of HDAC3. Rep-
resentative nuclei are indicated (N). γH2AX was present as a densely labeled spot associating with the nucleoli (stage I labeling, Figure 5). (C) Early in 
the cell death process, nuclei (N) in the GCL were still brightly labeled for AcH4. At this stage, γH2AX had begun to appear as a perinuclear ring (ar-
rowhead) (stage II labeling) and was not colocalized with the nuclear AcH4. Conversely, γH2AX did colocalize with HDAC3 at this stage. (D, E) These 
images illustrate the progressive movement of HDAC3 into the nuclei of dying cells. (D) HDAC3 was mainly present in the cytoplasm, but appeared 
to be concentrating around the nucleus (N). In E, HDAC3 was distributed in both the nucleus (asterisk in merged image), and colocalized with peri-
nuclear γH2AX (arrowhead). (F, G) After HDAC3 had begun to accumulate in the nuclei, a progressive decrease in AcH4 labeling was detected. Also at 
this point, γH2AX was present in the affected nuclei (stage III labeling, asterisk in G). (H) HDAC3 labeling continued to increase in the nuclei and was 
now colocalized with nuclear γH2AX (asterisk). (I, J) At this late stage of cell death, there was virtually no AcH4 left in the γH2AX-labeled cells (asterisk 
in I), while γH2AX and HDAC3 remained colocalized in the nuclei (asterisk in J). A graphic representation of these changes is also shown in additional 
file 2. Scale bar = 2 μm.Pelzel et al. BMC Neuroscience 2010, 11:62
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several disease models [37,44,45]. One of the conse-
quences of this imbalance could be an overall decrease in
histone acetylation, which leads to a decrease in gene
expression. Studies in which HDAC activity is suppressed
by HDAC inhibitors, presumably restoring the
HAT:HDAC balance, show that this treatment is able to
attenuate neuronal apoptosis. Several groups investigat-
ing models of polyglutamine expansion neurodegenera-
tive diseases, such as Huntington's disease, for example,
have used HDAC inhibitors to prevent cell loss [38,46-
48]. In these models, the relative increase in HDAC activ-
ity has been hypothetically attributed to a decrease in
HAT activity resulting from the sequestration and degra-
dation of the acetyltransferase, CREB binding protein
(CBP) [38,46], while HDAC activity levels remain
unchanged [49]. This model of neurodegeneration
implies that the relative increase in HDAC activity is a
passive consequence of the selective loss of CBP. Our
data, although consistent with the idea that HDAC activ-
ity is relatively increased, suggest that this change is
reflective of an active increase in nuclear HDAC levels in
dying RGCs, associated with both a modest increase in
HDAC gene expression and the translocation of an active
protein. In fact, nuclear HAT activity assays show no sig-
nificant changes in overall acetyltransferase activity in
retinas harvested from eyes after ONC (data not shown).
The overall importance of HDAC activity in the process
of RGC death can be probed with HDAC inhibitors such
as TSA. TSA pretreatment was able to attenuate the
down regulation of at least one gene normally expressed
in RGCs (Fem1cR3). Consistent with the other reports
showing a protective effect in models of neurodegenera-
tion, TSA was also able to provide a modest protective
effect to RGCs after ONC. The underlying cause for this
latter effect is not known and may be due to a variety of
factors, such as stabilizing the balance between HAT and
HDAC activity or allowing for increased acetylation of
factors such as Sp1, which has been shown to be neuro-
protective in a model of hypoxic stress [50]. Conversely, it
is equally possible that maintaining normal gene expres-
sion may have a secondary protective effect to the RGCs.
For example, previously we showed that the anti-apop-
totic gene BclX  was down-regulated after optic nerve
crush in rats [14]. Preventing this decrease could result in
an increase in RGC resistance to a damaging stimulus by
antagonizing the actions of proteins like BAX.
Although several studies have linked an increase in
HDAC activity to neuronal death, others have demon-
strated that the overexpression of HDACs can be neuro-
protective. Chen and Cepko showed that the
overexpression of HDAC4 led to increased protein stabil-
ity of the transcriptional activator HIF1α, which had a
protective effect in a model of photoreceptor degenera-
tion [51]. A related study demonstrated that part of the
beneficial effect of HDAC4 on HIF1α transcriptional
activity was due to HIF1α's increased ability to bind the
histone acetyltransferase, p300 [52], which could be ben-
eficial during neurodegeneration when fewer active HATs
are available [37,44]. In these cases, the protective effect
of increased HDAC activity appeared to be restricted to
cytoplasmic activity on non-histone substrates.
Irrespective of the principal function of HDAC activity
during cell death, the phenomenon of gene silencing is
likely going to act as a barrier to regaining normal cell
function in neuroprotective strategies. Bax-deficient
RGCs, which are completely resistant to apoptosis after
ONC, for example, can remain in a genetically silent, het-
erochromatic state for months following injury (unpub-
lished data). Similarly, inhibition of HDAC activity using
TSA, still resulted in some cell atrophy characterized by
soma shrinkage. Shrinkage of RGCs after optic nerve
damage has been described by others [53], including in
Bax-/- RGCs [54]. This atrophy response may be indica-
tive of the apoptotic volume decrease described in some
neuronal cell types [55], which is considered to be a very
early event in the apoptotic program and is regulated by a
rapid efflux of intracellular potassium in many neurons,
including retinal ganglion cells [56,57]. The effects we
observe in TSA-treated mice suggest that epigenetic
changes leading to gene silencing is downstream of the
apoptotic volume decrease. Nevertheless, a complete
understanding of the early changes in affected ganglion
cells remains an important consideration for neuropro-
tective strategies. Clearly, regaining normal cell function
will ultimately require reactivation of normal gene
expression, meaning reversal of epigenetic changes asso-
ciated with silenced genes.
Conclusions
In summary, this study demonstrates that a change in his-
tone acetylation levels, particularly in the promoter
regions of silenced genes, may be part of the underlying
mechanism of apoptotic gene silencing. In addition, there
is some evidence indicating that HDAC3 may be the pre-
dominant HDAC isoform responsible for apoptotic his-
tone deacetylation in dying RGCs. Initial HDAC
inhibition studies indicate that TSA can prevent gene
silencing and has a neuroprotective effect, suggesting that
histone deacetylation may be a critical stage in the apop-
totic pathway.
Methods
Experimental animals and optic nerve crush
All mice were handled in accordance with the Association
for Research in Vision and Ophthalmology statement for
the use of animals for research. The majority of experi-
ments were conducted on CB6F1 mice, which have been
used in the past by our group to quantify cell loss andPelzel et al. BMC Neuroscience 2010, 11:62
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changes in RGC transcript levels, as a result of ONC. In
some experiments, however, ROSA3, a substrain of C57BL/
6 mice [12], were used to utilize the expression of βGEO
marker protein as a way to more precisely quantify RGC-
specific gene expression. These latter mice express βGEO as
the result of transcription of the Fem1c gene, which is pre-
dominantly RGC-specific in the retina. They also exhibit
similar kinetics of cell loss observed in the CB6F1 strain.
For both strains, a random mixture of males and females
between the ages of 4-6 months were used. ONC was per-
formed unilaterally as described previously to initiate
degeneration of the retinal ganglion cells [30]. Retinas were
harvested 1, 3, 5, 7, or 14 days post ONC as indicated.
In some cases, retinal ganglion cells were retrogradely
labeled with the tracer dye, fluorogold (Molecular Probes,
Eugene, OR). Labeling was performed by first exposing
the superior collicli on each side of the brain and placing
a small piece of gel-foam, soaked in 0.9% NaCl containing
2% fluorogold, to each exposed surface. ONC surgery was
performed 3 days after dye application.
HDAC activity assay and nuclear protein extraction
Nuclear proteins were extracted from whole retinas accord-
ing to Andrews and Faller (1991). Protein concentration
was determined using a BCA protein assay kit (Pierce,
Rockford, IL). HDAC activity assays were performed using
a Fluor de Lys kit (BIOMOL International, Plymouth Meet-
ing, PA). Triplicate samples containing 4 μg of protein each
were loaded in an opaque 96-well plate with Fluor de Lys
substrate at a final concentration of 150 μM. Following a 20
minute incubation at room temperature, 1 × Fluor de Lys
developer with trichostatin A was added to stop the reac-
tion and develop the fluorescent signal. Plates were read
using a CytoFluor plate reader at 360 nm excitation and 440
nm emission wavelengths (Perkin Elmer, Waltham, MA).
All samples were corrected to a buffer-only blank and nor-
malized to the HeLa extract controls.
Western blot analysis
Western blot analysis on nuclear and cytoplasmic retinal
protein fractions (see above) was performed as previously
described [58] with the following modifications. Each
fraction was loaded as a single lane (500 μg) on
separate12% polyacrylamide gels and transblotted onto
Immobilon P (Millipore, Inc, Billerica, MA). Membranes
were stained with Ponceau S, cut into strips, and probed
with various antibodies. Rabbit polyclonal antibodies for
HDACs 1-5 (Santa Cruz, city CA) and anti-acetyl-histone
H4 ChIP grade rabbit antiserum (Millipore, Inc) were
used at a 1:100 dilution. Goat anti-rabbit secondary anti-
bodies, conjugated to alkaline phosphatase, were used at
a 1:500 dilution (Jackson ImmunoResearch Laboratories
Inc, West Grove, PA). Blots were color developed using
NBT and BCIP and digitally scanned.
Evaluation of transcripts in the retina by quantitative PCR
Total retinal RNA was isolated at 1, 3, and 7 days post
ONC and 2 μg was used for cDNA synthesis with reverse
transcriptase and oligo(dT) [11]. The resulting cDNA was
diluted 10-fold and 1 μl was used for each qPCR reaction
with SYBR Green PCR master mix (Applied Biosystems,
Foster City, CA) and the appropriate HDAC primers
(Table 1), as described previously [59]. Each primer set
was optimized, and the resulting amplimer cloned and
sequenced to confirm identity. Quantitative PCR was
conducted on triplicate samples in each run using an ABI
7300 Real Time PCR system (Applied Biosystems). Tran-
script quantification was based on standard curves of
each target amplimer and the absolute value for copy
number was normalized to S16  ribosomal protein
mRNA. The values are expressed as the ratio of crush:
control and normalized to the day 0 ratio that was set at 1.
In addition to evaluating individual transcripts in sepa-
rate experiments, a qPCR mini array was developed that
allowed us to examine 15 different mRNAs simultane-
ously during a single run. Each 96-well plate of the array
contained triplicate assays for 5 RGC-specific genes
(Thy1, Brn3b, Scng, Nrn1, Fem1c), 4 genes that are abun-
dantly expressed in RGCs, and reportedly decline in
expression, but are not necessarily RGC-specific (TrkB,
Nfl, BclX, Tubb3), 4 genes whose expression likely
increase in damaged retinas (Bim, Gap43, Hsp27, Gfap),
and 2 control genes (Gad67 and S16). Two complete sam-
ples could be simultaneously examined on each plate.
Primer design (T able 2) and PCR conditions were first
normalized so that efficient amplification was obtained
for all targets under the same PCR conditions. Sample
quantification was carried out as described above, using a
common standard curve for the entire plate.
Immunofluorescence and quantification of AcH4
Indirect immunofluorescence on 5 μm thick retinal cryo-
sections was done as described previously [60]. Primary
antibodies included γH2AX (monoclonal, Millipore, Inc),
HDAC2, HDAC3, and AcH4 (previously mentioned) and
were used at a 1:100 dilution. Secondary antibodies used
were goat anti-rabbit with a Texas Red label (1:100) and
goat anti-mouse with a FITC label (1:100) (both from Jack-
son ImmunoResearch Laboratories). The images were
obtained using a Zeiss Axioplan 2 Imaging microscope
with Axiovision 4.6.3.0 software (Carl Zeiss MicroImaging,
Inc., Thornwood, NY) and viewed in Adobe Photoshop.
To quantify AcH4 staining, nuclear pixel intensity was
measured in the ganglion cell (GCL) and inner nuclear
layers (INL) using the outline function of the Zeiss Axio-
vision software. A minimum of 99 cells was counted in
each layer and the mean pixel intensity per nucleus was
calculated as a function of the nuclear area (in μm2). The
calculated pixel intensity of GCL nuclei was normalizedPelzel et al. BMC Neuroscience 2010, 11:62
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Table 1: Primers for ChIP and qPCR analysis
Gene Name Primer Sequences Size of product (bp) Positiona
Hdac1 5'-GTCAAAGGAGCCCACGCCAG-3' 603 +555/+1157
5'-GTTGACAGCTTCGGGGAGGC-3'
Hdac2 5'-ATGGCGTACAGTCAAGGAGG-3' 359 +209/+568
5'-AGCAACTGAACCACCCGTGG-3'
Hdac3 5'-GTATGACAGGACTGACGAGG-3' 168 +528/+695
5'-TTTCCTTCCCACCACAGAGG-3'
Hdac4 5'-CATCCCCAAGCCAAGCGAGC-3' 619 +1521/+2140
5'-CCGTCTGTAGCTCCTCCAGG-3'
Hdac5 5'-CTGTGCCTCATCAGGCCCTG-3' 642 +1919/+2560
5'-CCACGCTCAGCTTCTGCTGC-3'
Thy1  5'-CTGGAATCAAAGGTGTGAGC-3' 190 -288/-98
promoter 5'-CCCCTCTCTTTATCCCCTTC-3'
Brn3b  5'-CTGAGGTCTGAAGCCAGAGC-3' 266 +17/+282
promoter 5'-ACGCCTGCTTGCTGTTCAGG-3'
Fem1c  5'-TCCGCAGCCTTTCAGGATGC-3' 188 -255/-67
promoter 5'-AGTGCGCCTGCGTACTAAGG-3'
Nrn1  5'-AACAATCGAGTGGGCGCACC-3' 251 -137/+114
promoter 5'-AAGTACAGCCTCACGCCCACG-3'
BclX  5'-ATCTGGTCGATGGAGGAACC-3' 214 +93/+326
promoter 5'-AATCTATCTCCGGCGACAGC-3'
Bim  5'-AAAGCAAGGGCGGAGGGACG-3' 238 -369/-132
promoter 5'-CTGTCCTGCAGTTTGCGTGC-3'
cJun  5'-AACACAAGCCGAAGCTGAGC-3' 263 -265/-2
promoter 5'-AGTCCTTATCCAGCCTGAGC-3'
a Indicates position (in base pairs) relative to the transcriptional start site (+1)
to the calculated pixel intensity of nuclei of the INL and
the final calculated intensity was expressed as a ratio of
crush:control.
Chromatin immunoprecipitation (ChIP) assays
Acetyl-histone H4 ChIP assays were performed as out-
lined by the manufacturer (Millipore). In each assay, 6
retinas were pooled and half of each sample was mixed
with either AcH4 antibody or normal rabbit serum for a
control (Jackson ImmunoResearch Laboratories). The
supernatant obtained from the normal serum samples
following immunoprecipitation was regarded as the
input. DNA from immunopreciptates was unlinked from
protein complexes and purified further by phenol/chloro-
form extraction. Samples were analyzed in triplicate
using qPCR as described above. The data obtained from
qPCR were analyzed by subtracting the normal serum
samples from the AcH4 immunoprecipitated samples and
converting this to a percentage of the total input. These
numbers were then expressed as a ratio of crush:control
and normalized to the day 0 values.
HDAC inhibitor studies
To inhibit HDAC activity in the retina, TSA was injected
either intraperitoneally (1 mg/kg in DMSO) 24 hours
prior to ONC surgery or intravitreally (1 μl of 20 μM TSA
in DMSO) immediately after ONC surgery. Vehicle injec-
tions consisted of an equal volume of DMSO. The effects
of TSA on gene expression were conducted on Fem1cR3/+
mice, which express the βGEO enzyme predominantly in
RGCs in the retina. The level of βGeo expression was
analyzed using two methods. Firstly, the level of βGEO
activity in individual retinas was quantified by β-Galacto-
sidase solution assay (Promega, Madison, WI) 5 days post
ONC. The plates were read with an ELX800 microplate
reader (Bio-Tek Instruments Inc., Winooski, VT). Dupli-
cate samples of each eye was measured and total activity
was calculated after subtraction of the β-Galactosidase
activity measured in wild-type mice and corrected to the
amount of total protein loaded in each sample. Secondly,
βGEO expressing cells were identified histochemically, 5
days post ONC, by staining retinal preparations with X-
Gal, followed by whole mounting as previously describedPelzel et al. BMC Neuroscience 2010, 11:62
http://www.biomedcentral.com/1471-2202/11/62
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[12]. To assess the effects of TSA on RGC loss, a 1 mg/kg
intraperitoneal injection of TSA was administered 24
hours prior to ONC of adult CB6F1 mice. Two weeks
after ONC, cells in the GCL were Nissl-stained and
counted and compared to controls [33].
Statistical analysis
Data was collected from a minimum of 3 independent
samples in all experiments, and shown as the mean ±
Standard Error in graphs. All statistical analyses were
performed using the Student's t-test with statistical sig-
nificance set at P ≤ 0.05.
Additional material
Additional file 1 Localization of HDACs 2 and 3 before and after optic 
nerve crush. Photomicrographs of the individual channels for the merged 
images of Figure 3B. Sections from control retinas and retinas 3 days after 
optic nerve crush (ONC) were labeled with antibodies against HDAC2 or 
HDAC3 and counter-stained with DAPI to highlight nuclei. High-magnifica-
tion images of the GCL are shown. (A, B) In control and crush retinas, HDAC2 
labeling (red) was present in the nuclei of cells in the GCL, as determined by 
DAPI staining (blue). (C) In control retinas, HDAC3 labeling had a diffuse, cyto-
plasmic appearance with minimal overlap with nuclear DAPI staining. (D) At 3 
days post ONC, many cells in the GCL exhibited nuclear HDAC3 labeling that 
coincided with DAPI staining of the nuclei. Scale bar = 5 μm.
Table 2: Primers for qPCR mini array analysis
Gene Name Primer Sequences Size of product (bp)
Thy1 5'-CTTGCAGGTGTCCCGAGGGC-3' 379
5'-CTGAACCAGCAGGCTTATGC-3'
Brn3b 5'-TCTTCCAACCCCACCGAGC-3' 157
5'-GTGGTAAGTGGCGTCCGGCTTG-3'
Sncg 5'-GACCAAGCAGGGAGTAACGG-3' 240
5'-TCCAAGTCCTCCTTGCGCAC-3'
Nrn1 5'-TTCACTGATCCTCGCGGTGC-3' 238
5'-TACTTTCGCCCCTTCCTGGC-3'
Fem1c 5'-GAAGTGTCCAACCGCCATGG-3' 292
5'-TTGTCTGGGCATGGTGCG-3'
TrkB 5'-GTCTGACCTGATCCTGACGG-3' 280
X5'-CCCAACGTCCCAGTACAAGG-3'
Nfl 5'-AGCACGAAGAGCGAGATGGC-3' 173
5'-TGCGAGCTCTGAGAGTAGCC-3'
BclX 5'-TTGGACAATGGACTGGTTGA-3' 780
5'-GTAGAGTGGATGGTCAGTG-3'
Tubb3 5'-GTTCTGGGAGGTCATCAGCG-3' 207
5'-TCGGGCCTGAATAGGTGTCC-3'
Bim 5'-TCTGAGTGTGACAGAGAAGG-3' 378
5'-CTCCTGAGACTGTCGTATGG-3'
Gap43 5'-TGAGCAAGCGAGCAGAAA-3' 199
5'-GCAGCCTTATGAGCCTTA-3'
Hsp27 5'-CGCAACAGCAGTCATGTCGG-3' 257
5'-GGCTCACATCCAGAAACGCC-3'
Gfap 5'-CAAACTGGCTGATGTCTACC-3' 269
5'-AGAACTGGATCTCCTCCTCC-3'
Gad67 5'-TCTTCCACTCCTTCGCCTGC-3' 279
5'-GGAGAAGTCGGTCTCTGTGC-3'
S16 5'-CACTGCAAACGGGGAAATGG-3' 198
5'-TGAGATGGACTGTCGGATGG-3'
All primer pairs were designed to span at least one intron.Pelzel et al. BMC Neuroscience 2010, 11:62
http://www.biomedcentral.com/1471-2202/11/62
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